Industry Sites Contact us
Expert advice

Certified HD clinical trial-ready sites 

What does it take to become a HD clinical trial certified site? For inquiries regarding HD-CTTF activities please contact cttf-hd@euro-hd.net

The HD-CTTF aims to foster the conception, development and execution of high quality and patient relevant clinical research in HD.

HD trials – clinical trials Huntington’s

The Clinical Trials Task Force – Huntington’s disease (CTTF-HD)

It is an entity that works under the auspices of CHDI and EHDN. Experts in clinical drug development, clinical research methodology, clinical operations, and Huntington disease form the core team of the CTTF. In addition, there is a larger group of experts in sub-specialty disciplines, like toxicology, pharmacokinetics, statistics, clinimetrics, cognition, motor and behavioral assessments that are engaged with the CTTF. These experts will participate in meetings or problem discussions on case by case basis.

The CTTF-HD provides assistance on request to partners involved in Huntington’s disease (HD) therapy research.

The CTTF-HD was established in 2012 as part of the implementation of the European Huntington’s Disease Network’s (EHDN) Strategic Scientific Plan. The CTTF-HD Chair and members were appointed by the EHDN Executive Committee with the remit of providing expertise in HD clinical research within the EHDN. The remit was soon expanded, in a direct collaboration with CHDI, to included all external partners interested in developing a therapeutic strategy in HD including those that reach out to CHDI for advise in matters regarding clinical development plans. There are a set of criteria ( see procedures) a partner much meet to have access to the resources made available by the CTTF)